Mirvetuximab Soravtansine (IMG853) in Folate Receptor Alpha-expressing TNBC
Clinical trial NCT03045393 · WITHDRAWN
Trial details
- NCT number
- NCT03045393
- Sponsor
- Duke University
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-17
- Primary completion
- 2018-02-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.